Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70789) 70789
Newsletter (2997) 2997
Newspaper Article (284) 284
Book / eBook (77) 77
Magazine Article (59) 59
Conference Proceeding (38) 38
Web Resource (25) 25
Streaming Video (13) 13
Dissertation (12) 12
Transcript (12) 12
Book Chapter (7) 7
Journal / eJournal (5) 5
Publication (4) 4
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59179) 59179
science & technology (57935) 57935
life sciences & biomedicine (52461) 52461
oncology (33306) 33306
antineoplastic agents (29855) 29855
female (28611) 28611
biological and medical sciences (28292) 28292
medical sciences (27689) 27689
animals (23909) 23909
male (23520) 23520
pharmacology. drug treatments (20702) 20702
cancer (19021) 19021
middle aged (16782) 16782
antineoplastic agents - therapeutic use (16356) 16356
mice (15987) 15987
antineoplastic agents - pharmacology (14023) 14023
tumors (13977) 13977
adult (13614) 13614
aged (13553) 13553
chemotherapy (13397) 13397
immunotherapy (12149) 12149
hematology (11398) 11398
cell line, tumor (11165) 11165
immunology (10800) 10800
antimitotic agents (9699) 9699
care and treatment (9355) 9355
treatment outcome (9123) 9123
research (8585) 8585
antineoplastic combined chemotherapy protocols - therapeutic use (8186) 8186
apoptosis (7403) 7403
health aspects (6304) 6304
analysis (5871) 5871
pharmacology & pharmacy (5809) 5809
apoptosis - drug effects (5736) 5736
science & technology - other topics (5454) 5454
prognosis (5192) 5192
multidisciplinary sciences (5156) 5156
antineoplastic agents - administration & dosage (5015) 5015
antineoplastic agents - adverse effects (4993) 4993
neoplasms - drug therapy (4930) 4930
tumor cells, cultured (4841) 4841
medicine (4713) 4713
drug therapy (4616) 4616
aged, 80 and over (4570) 4570
hematologic and hematopoietic diseases (4508) 4508
research article (4479) 4479
antibodies, monoclonal - therapeutic use (4439) 4439
cell biology (4335) 4335
cancer therapies (4204) 4204
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (4114) 4114
adolescent (4016) 4016
medicine & public health (3980) 3980
cell proliferation - drug effects (3973) 3973
breast cancer (3972) 3972
combined modality therapy (3934) 3934
mice, inbred balb c (3907) 3907
metastasis (3877) 3877
science (3823) 3823
proteins (3741) 3741
medicine, research & experimental (3735) 3735
research & experimental medicine (3734) 3734
dose-response relationship, drug (3718) 3718
neoplasms - immunology (3582) 3582
gene expression (3578) 3578
biochemistry & molecular biology (3566) 3566
transplantation (3499) 3499
retrospective studies (3425) 3425
mice, inbred c57bl (3417) 3417
leukemia (3345) 3345
flow cytometry (3301) 3301
medical research (3287) 3287
abridged index medicus (3168) 3168
patients (3167) 3167
mice, nude (3142) 3142
child (3116) 3116
cancer research (3094) 3094
xenograft model antitumor assays (3079) 3079
cytotoxicity (3069) 3069
time factors (3049) 3049
clinical trials (2937) 2937
survival analysis (2935) 2935
disease-free survival (2919) 2919
signal transduction (2888) 2888
kinases (2878) 2878
general aspects (2821) 2821
oncology, experimental (2757) 2757
genetic aspects (2751) 2751
antineoplastic combined chemotherapy protocols - adverse effects (2736) 2736
mutation (2713) 2713
melanoma (2709) 2709
breast neoplasms - drug therapy (2704) 2704
risk factors (2704) 2704
cell survival - drug effects (2635) 2635
survival rate (2622) 2622
neoplasm staging (2584) 2584
t-lymphocytes - immunology (2567) 2567
drug resistance, neoplasm (2539) 2539
signal transduction - drug effects (2498) 2498
stem cells (2485) 2485
toxicity (2480) 2480
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (31) 31
Online Resources - Online (25) 25
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Gerstein Science - Periodical Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Humber River Regional Hospital - Online (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Periodicals (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (73152) 73152
Japanese (647) 647
German (284) 284
Russian (263) 263
French (220) 220
Chinese (214) 214
Italian (88) 88
Polish (68) 68
Spanish (67) 67
Hungarian (34) 34
Danish (24) 24
Portuguese (22) 22
Norwegian (20) 20
Czech (15) 15
Dutch (15) 15
Swedish (15) 15
Romanian (14) 14
Croatian (7) 7
Ukrainian (7) 7
Finnish (6) 6
Serbian (4) 4
Bulgarian (3) 3
Slovak (3) 3
Hebrew (2) 2
Turkish (2) 2
Amharic (1) 1
Bosnian (1) 1
Icelandic (1) 1
Korean (1) 1
Latin (1) 1
Nauru (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Antimicrobial agents and chemotherapy
American Society for Microbiology
Antimicrobial agents and chemotherapy, ISSN 0066-4804
Antibiotics | Chemotherapy | Drug Therapy
Journal
Details down arrow
2. Full Text Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
by Jeffrey S. Weber and Katharina C. Kähler and Axel Hauschild
Journal of clinical oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2691 - 2697
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Molecular cancer therapeutics
American Association for Cancer Research
Molecular cancer therapeutics, ISSN 1535-7163, 2001
Prevention | Treatment | Therapeutics | Cancer
Journal
Details down arrow
4. Full Text Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
by Trabanelli, Sara and Chevalier, Mathieu F and Martinez-Usatorre, Amaia and Gomez-Cadena, Alejandra and Salomé, Bérengère and Lecciso, Mariangela and Salvestrini, Valentina and Verdeil, Grégory and Racle, Julien and Papayannidis, Cristina and Morita, Hideaki and Pizzitola, Irene and Grandclément, Camille and Bohner, Perrine and Bruni, Elena and Girotra, Mukul and Pallavi, Rani and Falvo, Paolo and Leibundgut, Elisabeth Oppliger and Baerlocher, Gabriela M and Carlo-Stella, Carmelo and Taurino, Daniela and Santoro, Armando and Spinelli, Orietta and Rambaldi, Alessandro and Giarin, Emanuela and Basso, Giuseppe and Tresoldi, Cristina and Ciceri, Fabio and Gfeller, David and Akdis, Cezmi A and Mazzarella, Luca and Minucci, Saverio and Pelicci, Pier Giuseppe and Marcenaro, Emanuela and McKenzie, Andrew N. J and Vanhecke, Dominique and Coukos, George and Mavilio, Domenico and Curti, Antonio and Derré, Laurent and Jandus, Camilla
Nature communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1 - 14
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lymphoid cells | Leukemia | Hypersensitivity | Inflammation | Interleukin 13 | Suppressor cells | Dermatitis | Polyposis | Immunity | Monocytes | Immunosuppression | Atopic dermatitis | Remission | Disruption | Prostate cancer | Prostate | Retinoic acid | Cancer | Tumors | Tretinoin | Index Medicus | Life Sciences | Immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
by Ma, Yuting and Adjemian, Sandy and Mattarollo, Stephen R and Yamazaki, Takahiro and Aymeric, Laetitia and Yang, Heng and Portela Catani, João Paulo and Hannani, Dalil and Duret, Helene and Steegh, Kim and Martins, Isabelle and Schlemmer, Frederic and Michaud, Mickaël and Kepp, Oliver and Sukkurwala, Abdul Qader and Menger, Laurie and Vacchelli, Erika and Droin, Nathalie and Galluzzi, Lorenzo and Krzysiek, Roman and Gordon, Siamon and Taylor, Philip R and Van Endert, Peter and Solary, Eric and Smyth, Mark J and Zitvogel, Laurence and Kroemer, Guido
Immunity (Cambridge, Mass.), ISSN 1074-7613, 04/2013, Volume 38, Issue 4, pp. 729 - 741
Life Sciences & Biomedicine | Immunology | Science & Technology | Anthracyclines - adverse effects | Dendritic Cells - immunology | Monocyte-Macrophage Precursor Cells - immunology | Adoptive Transfer | Antineoplastic Agents - administration & dosage | CD11c Antigen - metabolism | Anthracyclines - administration & dosage | Antineoplastic Agents - adverse effects | Neoplasms, Experimental - immunology | Antigens, Ly - metabolism | Granulocyte Precursor Cells - immunology | Antigens, Neoplasm - immunology | Mice, Inbred C57BL | Antigen-Presenting Cells - immunology | Receptors, Purinergic - metabolism | Cell Movement - drug effects | Nucleotidases - metabolism | Animals | Cell Differentiation - drug effects | Cell Line, Tumor | Mice | CD11b Antigen - metabolism | Immunity, Cellular | Neoplasms, Experimental - drug therapy | Apoptosis | Antimitotic agents | Antigens | Employee recruitment | Chemotherapy | Antineoplastic agents | Cancer | Tumors | Medical research | Immune system | Index Medicus | Life Sciences | Immunotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma
by Choueiri, Toni K and Fishman, Mayer N and Escudier, Bernard and McDermott, David F and Drake, Charles G and Kluger, Harriet and Stadler, Walter M and Perez-Gracia, Jose Luis and McNeel, Douglas G and Curti, Brendan and Harrison, Michael R and Plimack, Elizabeth R and Appleman, Leonard and Fong, Lawrence and Albiges, Laurence and Cohen, Lewis and Young, Tina C and Chasalow, Scott D and Ross-Macdonald, Petra and Srivastava, Shivani and Jure-Kunkel, Maria and Kurland, John F and Simon, Jason S and Sznol, Mario
Clinical cancer research, ISSN 1078-0432, 11/2016, Volume 22, Issue 22, pp. 5461 - 5471
Life Sciences & Biomedicine | Oncology | Science & Technology | Prospective Studies | Humans | Middle Aged | Kidney Neoplasms - immunology | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Renal Cell - immunology | Lymphocytes - immunology | Chemokine CXCL10 - immunology | Everolimus - therapeutic use | Female | Antibodies, Monoclonal - immunology | Kidney Neoplasms - therapy | Tumor Microenvironment - drug effects | Everolimus - immunology | Antineoplastic Agents - immunology | Immunologic Factors - immunology | Chemokine CXCL9 - immunology | B7-H1 Antigen - immunology | Tumor Microenvironment - immunology | Up-Regulation - drug effects | Up-Regulation - immunology | Interferon-gamma - immunology | Lymphocytes - drug effects | Carcinoma, Renal Cell - therapy | Immunologic Factors - therapeutic use | Index Medicus | antibody immunotherapy | immunomodulation | nivolumab | immune responses to cancer | phase I-III trials-GU cancer-other | PD-1 inhibition | GU cancer-other
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Tumor-Associated Neutrophils Recruit Macrophages and T-regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
by Zhou, Shao-Lai and Zhou, Zheng-Jun and Hu, Zhi-Qiang and Huang, Xiao-Wu and Wang, Zheng and Chen, Er-Bao and Fan, Jia and Cao, Ya and Dai, Zhi and Zhou, Jian
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2016, Volume 150, Issue 7, pp. 1646 - 1658.e17
Gastroenterology and Hepatology | Liver Cancer | Neovascularization | Immune Response | Mouse Model | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Niacinamide - analogs & derivatives | Antineoplastic Agents - immunology | Humans | Liver Neoplasms - drug therapy | Neutrophils - immunology | Liver Neoplasms - immunology | Niacinamide - immunology | Drug Resistance, Neoplasm - immunology | Phenylurea Compounds - immunology | Antineoplastic Agents - administration & dosage | Neutrophil Infiltration | Disease Progression | Niacinamide - administration & dosage | T-Lymphocytes, Regulatory - immunology | Animals | Carcinoma, Hepatocellular - drug therapy | Phenylurea Compounds - administration & dosage | Carcinoma, Hepatocellular - pathology | Cell Line, Tumor | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - immunology | Mice | Macrophages - immunology | Antimitotic agents | Liver | Development and progression | Hepatoma | Research institutes | Antineoplastic agents | Macrophages | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign
by Poschke, Isabel and Mougiakakos, Dimitrios and Hansson, Johan and Masucci, Giuseppe V and Kiessling, Rolf
Cancer research (Chicago, Ill.), ISSN 0008-5472, 06/2010, Volume 70, Issue 11, pp. 4335 - 4345
Tumors of the skin and soft tissue. Premalignant lesions | Dermatology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Melanoma - blood | Antigens, CD - immunology | Cell Communication - immunology | Immunoglobulins - immunology | Antigens, CD - biosynthesis | Humans | Membrane Glycoproteins - biosynthesis | Middle Aged | Lectins, C-Type - immunology | Oxidative Stress - immunology | Male | Lectins, C-Type - biosynthesis | Cell Adhesion Molecules - immunology | Interleukin-4 Receptor alpha Subunit - biosynthesis | Myeloid Cells - immunology | Calgranulin B - immunology | Aged, 80 and over | Adult | Female | Receptors, Cell Surface - biosynthesis | B7-1 Antigen - biosynthesis | Membrane Glycoproteins - immunology | Immunoglobulins - biosynthesis | Calgranulin B - biosynthesis | B7-1 Antigen - immunology | Cell Adhesion Molecules - biosynthesis | Lymphocyte Activation | Lipopolysaccharide Receptors - immunology | Interleukin-4 Receptor alpha Subunit - immunology | Receptors, Cell Surface - immunology | STAT3 Transcription Factor - biosynthesis | Melanoma - immunology | Interferon-gamma - immunology | T-Lymphocytes - immunology | Aged | HLA-DR Antigens - immunology | STAT3 Transcription Factor - immunology | Interferon-gamma - biosynthesis | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
by Wagner, Klaus and Wolchok, Jedd D and Sharma, Padmanee and Allison, James P
Nature reviews. Cancer, ISSN 1474-175X, 11/2011, Volume 11, Issue 11, pp. 805 - 812
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Antineoplastic Agents - immunology | Humans | Ipilimumab | Monitoring, Immunologic | Tissue Extracts - immunology | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Tissue Extracts - therapeutic use | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Randomized Controlled Trials as Topic | Melanoma - immunology | Immunotherapy | Melanoma - therapy | Antibodies, Monoclonal - immunology | Care and treatment | Melanoma | Development and progression | Genetic aspects | Research | Health aspects | Prostate cancer | Immune response | Reviews | biomarkers | Survival | Immunosuppressive agents | Metastases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
by Galustian, Christine and Galustian, Christine and Meyer, Brendan and Meyer, Brendan and Labarthe, Marie-Christine and Labarthe, Marie-Christine and Dredge, Keith and Dredge, Keith and Klaschka, Deborah and Klaschka, Deborah and Henry, Jake and Henry, Jake and Todryk, Stephen and Todryk, Stephen and Chen, Roger and Chen, Roger and Muller, George and Muller, George and Stirling, David and Stirling, David and Schafer, Peter and Schafer, Peter and Bartlett, J Blake and Bartlett, J Blake and Dalgleish, Angus G and Dalgleish, Angus G
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 7/2009, Volume 58, Issue 7, pp. 1033 - 1045
Immunomodulatory drugs | Biomedicine | Immunology | Lenalidomide | T regulatory cells | Cancer Research | Oncology | Pomalidomide | IMiDs | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Immunotherapy | Pharmacology. Drug treatments | Forkhead Transcription Factors - immunology | Receptors, Nerve Growth Factor - immunology | Receptors, Transforming Growth Factor beta - immunology | Receptors, Nerve Growth Factor - drug effects | Humans | Receptors, Nerve Growth Factor - metabolism | Thalidomide - pharmacology | Colonic Neoplasms - metabolism | Receptors, OX40 - immunology | T-Lymphocytes, Regulatory - immunology | Thalidomide - analogs & derivatives | Receptors, OX40 - metabolism | Transforming Growth Factor beta - drug effects | Colonic Neoplasms - immunology | Forkhead Transcription Factors - metabolism | Interleukin-10 - metabolism | Female | Antineoplastic Agents - pharmacology | Forkhead Transcription Factors - antagonists & inhibitors | Immunosuppressive Agents - pharmacology | Receptors, Tumor Necrosis Factor - metabolism | Transforming Growth Factor beta - immunology | Glucocorticoid-Induced TNFR-Related Protein | T-Lymphocytes, Regulatory - drug effects | Animals | Receptors, Transforming Growth Factor beta - drug effects | Receptors, Transforming Growth Factor beta - metabolism | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Receptors, Tumor Necrosis Factor - immunology | Interleukin-10 - immunology | Transforming Growth Factor beta - metabolism | Receptors, Tumor Necrosis Factor - drug effects | Receptors, OX40 - antagonists & inhibitors | Care and treatment | Dexamethasone | Multiple myeloma | Angiogenesis inhibitors | Transforming growth factors | T cells | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights